MCID: HPT003
MIFTS: 56

Hepatitis a

Categories: Infectious diseases, Skin diseases, Liver diseases, Genetic diseases, Rare diseases, Gastrointestinal diseases, Immune diseases

Aliases & Classifications for Hepatitis a

MalaCards integrated aliases for Hepatitis a:

Name: Hepatitis a 12 41 42 14 69
Viral Hepatitis, Type a 12
Viral Hepatitis a 12

Classifications:



External Ids:

Disease Ontology 12 DOID:12549
MeSH 42 D006506
NCIt 47 C3096
SNOMED-CT 64 154347003 40468003
ICD10 33 B15.0 B15.9
UMLS 69 C0019159

Summaries for Hepatitis a

MedlinePlus : 41 your liver is the largest organ inside your body. it helps your body digest food, store energy, and remove poisons. hepatitis is an inflammation of the liver. one type, hepatitis a, is caused by the hepatitis a virus (hav). the disease spreads through contact with an infected person's stool. you can get it from eating food made by an infected person who did not wash their hands after using the bathroom drinking untreated water or eating food washed in untreated water putting into your mouth a finger or object that came into contact with an infected person's stool having close contact with an infected person, such as through sex or caring for someone who is ill most people do not have any symptoms. if you do have symptoms, you may feel as if you have the flu. you may also have yellowish eyes and skin, called jaundice. a blood test will show if you have hav. hav usually gets better in a few weeks without treatment. however, some people can have symptoms for up to 6 months. your doctor may suggest medicines to help relieve your symptoms. the hepatitis a vaccine can prevent hav. good hygiene can also help. wash your hands thoroughly before preparing food, after using the toilet, or after changing a diaper. international travelers should be careful about drinking tap water. nih: national institute of diabetes and digestive and kidney diseases

MalaCards based summary : Hepatitis a, also known as viral hepatitis, type a, is related to urticaria and granulomatous hepatitis, and has symptoms including abdominal pain, constipation and diarrhea. An important gene associated with Hepatitis a is HAVCR1 (Hepatitis A Virus Cellular Receptor 1), and among its related pathways/superpathways are Response to elevated platelet cytosolic Ca2+ and Formation of Fibrin Clot (Clotting Cascade). The drugs Aluminum hydroxide and Aluminum sulfate have been mentioned in the context of this disorder. Affiliated tissues include liver, testes and kidney, and related phenotype is neoplasm.

Disease Ontology : 12 A viral infectious disease that results_in inflammation located in liver, has material basis in Hepatitis A virus, which is transmitted_by ingestion of contaminated food or water, or transmitted_by direct contact with an infected person. The infection has symptom fever, has symptom fatigue, has symptom loss of appetite, has symptom nausea, has symptom vomiting, has symptom abdominal pain, has symptom clay-colored bowel movements, has symptom joint pain, and has symptom jaundice.

Wikipedia : 72 Hepatitis A is an infectious disease of the liver caused by the hepatitis A virus (HAV). Many cases have... more...

Related Diseases for Hepatitis a

Diseases in the Hepatitis family:

Hepatitis C Virus Autoimmune Hepatitis
Hepatitis B Hepatitis a
Hepatitis C Viral Hepatitis
Hepatitis D Hepatitis E

Diseases related to Hepatitis a via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 300)
id Related Disease Score Top Affiliating Genes
1 urticaria 29.4 IFNA2 TGFB1
2 granulomatous hepatitis 29.3 F2 F3 SERPINC1
3 hyperthyroidism 29.3 F2 F3
4 hiv-1 29.0 F2 SERPINC1
5 chickenpox 28.9 IFNA2 SERPINA1 TNF
6 malaria 28.5 ALB F3 HAVCR2 TGFB1 TNF
7 hepatocellular carcinoma 26.1 AFP ALB F2 GPT HSPA5 IFNA2
8 hepatitis 11.2
9 viral hepatitis 10.9
10 liver disease 10.8
11 congenital dyserythropoietic anemia 10.7 ALB TNF
12 luminal breast carcinoma 10.7 AFP ALB
13 tracheal calcification 10.6 GPT TNF
14 non-hodgkin lymphoma, during pregnancy 10.6 ALB F2
15 chancroid 10.6 AFP GPT
16 biemond syndrome 10.6 TGFB1 TNF
17 argyria 10.6 F2 GPT
18 clear cell variant infiltrating bladder urothelial carcinoma 10.6 AFP SERPINA1
19 polymyositis 10.6 AFP SERPINA1
20 fatty liver disease 10.6
21 oral cavity carcinoma in situ 10.5 ALB F2
22 burning mouth syndrome 10.5 F2 TNF
23 testicular spermatocytic seminoma 10.5 HAVCR1 SERPINA1
24 scrotal carcinoma 10.5 TGFB1 TNF
25 thymus small cell carcinoma 10.5 AFP F2
26 bladder sarcoma 10.5 ALB GPT TNF
27 social phobia 10.5 AFP F2
28 polysyndactyly with cardiac malformation 10.5 ALB SERPINA1
29 idiopathic peripheral autonomic neuropathy 10.5 ALB SERPINA1
30 hemopneumothorax 10.4 F2 IFNA2
31 screw worm infectious disease 10.4 ALB HAVCR1 TGFB1
32 plantar wart 10.4 TGFB1 TNF
33 anencephaly and spina bifida x-linked 10.4 SERPINA1 TNF
34 duane retraction syndrome 10.4 AFP ALB F2
35 potato nose 10.4 TGFB1 TNF
36 female infertility of uterine origin 10.4 ALB F2 GPT
37 patent foramen ovale 10.4 ALB GPT TGFB1
38 kohler's disease 10.3 ALB F2 GPT
39 acral lentiginous melanoma 10.3 ALB IFNA2 TNF
40 acute lymphocytic leukemia 10.3 ALB F2 GPT
41 orbital cancer 10.3 ALB F2 GPT
42 rete ovarii adenoma 10.3 ALB F2 TNF
43 rete ovarii cystadenofibroma 10.3 AFP SERPINA1
44 fallopian tube leiomyosarcoma 10.3 ALB F2 GPT
45 pyelitis 10.3 ALB F2 GPT
46 exocrine pancreatic insufficiency 10.3 ALB TGFB1 TNF
47 sex differentiation disease 10.3 AFP ALB SERPINA1
48 46,xy ovotesticular disorder of sex development 10.3 F2 F3
49 von willibrand disease, type 3 10.3 F2 F3
50 spinocerebellar ataxia 8 10.3 ALB F2 GPT

Graphical network of the top 20 diseases related to Hepatitis a:



Diseases related to Hepatitis a

Symptoms & Phenotypes for Hepatitis a

UMLS symptoms related to Hepatitis a:


abdominal pain, constipation, diarrhea, dyspepsia, fever, heartburn, icterus, nausea and vomiting, pruritus, gastrointestinal gas

MGI Mouse Phenotypes related to Hepatitis a:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 neoplasm MP:0002006 9.1 AFP ALB F3 HSPA5 TGFB1 TNF

Drugs & Therapeutics for Hepatitis a

Drugs for Hepatitis a (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 770)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Aluminum hydroxide Approved Phase 4,Phase 3,Phase 2,Phase 1 21645-51-2
2
Aluminum sulfate Approved Phase 4,Phase 3,Phase 1,Phase 2 10043-01-3
3
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
4
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 104987-11-3 445643 439492
5
Peginterferon alfa-2b Approved Phase 4,Phase 2,Phase 3,Phase 1 99210-65-8, 215647-85-1
6
Ribavirin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 36791-04-5 37542
7
Emtricitabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 143491-57-0 60877
8
Neomycin Approved, Vet_approved Phase 4 1404-04-2 8378
9
Adefovir Dipivoxil Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 142340-99-6 60871
10
Entecavir Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 142217-69-4 153941
11
Isoniazid Approved Phase 4,Phase 3,Phase 2 54-85-3 3767
12
Pyrazinamide Approved Phase 4,Phase 2,Phase 3 98-96-4 1046
13
Rifampin Approved Phase 4,Phase 2,Phase 3,Phase 1 13292-46-1 5458213 5381226
14
Peginterferon alfa-2a Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 198153-51-4 5360545
15
Lamivudine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 134678-17-4 60825
16
Telbivudine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 3424-98-4 159269
17
Orlistat Approved, Investigational Phase 4 96829-58-2 3034010
18
Acarbose Approved, Investigational Phase 4 56180-94-0 441184
19
Metformin Approved Phase 4,Phase 2,Phase 3,Phase 1 657-24-9 14219 4091
20
Pioglitazone Approved, Investigational Phase 4,Phase 3,Phase 2 111025-46-8 4829
21
Guaifenesin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 93-14-1 3516
22
Methadone Approved Phase 4,Phase 3,Phase 2,Phase 1 76-99-3 4095
23
Ritonavir Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 155213-67-5 392622
24
Amantadine Approved Phase 4,Phase 3,Phase 2 768-94-5 2130
25
Dopamine Approved Phase 4,Phase 3,Phase 2 51-61-6, 62-31-7 681
26
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Early Phase 1 83-43-2 6741
27
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Early Phase 1 50-24-8 5755
28
Ethiodized oil Approved Phase 4,Phase 3,Phase 2 8008-53-5
29
Benzocaine Approved Phase 4,Phase 2,Phase 3,Phase 1 1994-09-7, 94-09-7 2337
30
Mycophenolate mofetil Approved, Investigational Phase 4,Phase 3,Phase 2 128794-94-5 5281078
31
Mycophenolic acid Approved Phase 4,Phase 3,Phase 2 24280-93-1 446541
32
Nitazoxanide Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 55981-09-4 41684
33
Pentoxifylline Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 6493-05-6 4740
34
Chlorhexidine Approved, Vet_approved Phase 4 55-56-1 9552079 2713
35
Ursodeoxycholic acid Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 128-13-2 31401
36
Caspofungin Approved Phase 4 179463-17-3, 162808-62-0 468682 2826718
37
Simvastatin Approved Phase 4,Phase 3,Phase 1 79902-63-9 54454
38
Insulin Glargine Approved Phase 4 160337-95-1
39
Insulin-glulisine Approved Phase 4 207748-29-6
40
Zinc Approved Phase 4,Phase 2,Phase 3 7440-66-6 32051 23994
41
Acamprosate Approved, Investigational Phase 4 77337-76-9 71158
42
Ethanol Approved Phase 4,Phase 3,Phase 2,Phase 1 64-17-5 702
43
Thrombin Approved Phase 4,Phase 3,Phase 1
44
Simeprevir Approved Phase 4,Phase 3,Phase 2,Phase 1 923604-59-5 66576988
45
Sofosbuvir Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 1190307-88-0 45375808
46
Ledipasvir Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 1256388-51-8 67505836
47
Prednisone Approved, Vet_approved Phase 4,Phase 2,Phase 3 53-03-2 5865
48
rituximab Approved Phase 4,Phase 3,Phase 2,Phase 1 174722-31-7 10201696
49
Thymalfasin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 62304-98-7
50
Efavirenz Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 154598-52-4 64139

Interventional clinical trials:

(show top 50) (show all 4031)

id Name Status NCT ID Phase Drugs
1 PCV13 + Hepatitis A Vaccine for Adults Unknown status NCT01926860 Phase 4
2 A Randomized,Parallel-group Clinical Trial of Hepatitis B Vaccine With Different Dosages and Schedules in Healthy Adults Unknown status NCT02203357 Phase 4
3 Combination Hepatitis A and B Vaccine to Induce Immunity in Non-responders Unknown status NCT01126853 Phase 4
4 Adolescents' Response to Hepatitis B Vaccine Booster Dose Unknown status NCT01341275 Phase 4
5 Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine(Hecolin®) Unknown status NCT02189603 Phase 4
6 Hepatitis C in Renal Transplant Recipients Unknown status NCT02108301 Phase 4 tacrolimus-cyclosporine A
7 Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta Unknown status NCT00117533 Phase 4 pegylated IFN alfa-2b plus ribavirin
8 Emtricitabine for Naive Chinese Pregnant Chronic Hepatitis B Patients Unknown status NCT02327702 Phase 4 Emtricitabine
9 Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-responders Unknown status NCT01451801 Phase 4
10 Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy Unknown status NCT01341743 Phase 4 Entecavir;Entecavir, Adefovir;Entecavir, Adefovir
11 Hepatitis B Virus (HBV) Antibody (Anti-HBs) Booster Program for the Production of Hepatitis B Immune Globulin (HBIG) Unknown status NCT01311674 Phase 4
12 Reintroduction Regimens After Hepatitis During Anti-tuberculosis Treatment Unknown status NCT01395654 Phase 4 isoniazid, rifampin, pyrazinamide
13 Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous Treatment Unknown status NCT01724723 Phase 4 entecavir (BARACLUDE®)
14 Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis B Unknown status NCT00597259 Phase 4 Pegasys plus Entecavir;Entecavir
15 Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B Patients Unknown status NCT01148576 Phase 4 entecavir;entecavir;essentiale + entecavir;Vitamin E + entecavir
16 Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B Vaccine Unknown status NCT01548326 Phase 4 Atorvastatin;placebo
17 Entecavir for Chronic Hepatitis B Patients With Persistently Normal ALT Unknown status NCT01833611 Phase 4 Entecavir;placebo
18 Sustained Off-treatment Response After HBeAg Loss in Chronic Hepatitis B Patients Treated With Nucleos(t)Ide Analogues Unknown status NCT01911156 Phase 4 Continue NA treatment;Discontinue NA Treatment
19 Twinrix Alternative Schedule Study Unknown status NCT00216229 Phase 4
20 Emtricitabine for Naive Child Chinese Chronic Hepatitis B Patients Unknown status NCT02327676 Phase 4 Emtricitabine
21 Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis Unknown status NCT01998620 Phase 4 Ademetionine 2;Ademetionine 1;Ademetionine 3
22 Antiviral Efficacy of the Combination Treatment With Poly IC and Entecavir for Chronic Hepatitis B Unknown status NCT02532413 Phase 4 Poly IC;Entecavir
23 Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot Study Unknown status NCT01804387 Phase 4 telbivudine plus adefovir;lamivudine plus adefovir
24 Hansenula-derived Pegylated Interferon in Treatment of Patients With Chronic Hepatitis C Unknown status NCT01649245 Phase 4 Reiferon retard
25 Switch From Adefovir to Tenofovir in Chronic Hepatitis B for Suboptimal Response to Adefovir-based Combination Therapy Unknown status NCT01595633 Phase 4 Switching from adefovir (10mg/day) to tenofovir (300mg/day)
26 Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase Levels Unknown status NCT00575627 Phase 4 Peg-Interferon alpha2a plus Ribavirin
27 A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B Alone Unknown status NCT00354653 Phase 4 LAMIVUDINE
28 Increasing Cure Rate of Hepatitis C Therapy in Obese Hepatitis C Patients Unknown status NCT00871845 Phase 4 Orlistat
29 Add Vitamin D With Standard of Care for Chronic Hepatitis C Patients Unknown status NCT01439776 Phase 4
30 Efficacy and Safety of S-adenosyl-l-methionine in Treatment of Alcoholic Hepatitis With Cholestasis Unknown status NCT02024295 Phase 4 Ademethionine;Polyene Phosphatidyl choline;Ademethionine
31 Combination or Sequential Therapy of Peginterferon Alfa-2a and Entecavir for Patients With Chronic Hepatitis B Unknown status NCT01906580 Phase 4 Peg-IFNα-2a;Entecavir
32 The Effects of Oral Hypoglycemic Agents on Chronic Hepatitis C Patients Receiving Peg-Intron Plus Ribavirin Unknown status NCT01025765 Phase 4 Pioglitazone;Acarbose;Metformin
33 Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B Unknown status NCT01926288 Phase 4 Entecavir maleate tablets;blank Baraclude tablets;Blank maleate entecavir tablets;Baraclude tablets
34 A Two-year Study of Telbivudine in HBeAg Negative Hepatitis Unknown status NCT01521975 Phase 4 Telbivudine, Adefovir dipivoxil
35 Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Hepatocellular Carcinoma Unknown status NCT00834860 Phase 4 peginterferon alpha-2a and ribavirin
36 Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB) Unknown status NCT01380951 Phase 4 telbivudine
37 Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users Unknown status NCT01105611 Phase 4 Raltegravir;Atazanavir/Ritonavir
38 Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA) Unknown status NCT00127777 Phase 4 Amantadine sulphate (in addition to standard treatment)
39 Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B Patients Unknown status NCT01436539 Phase 4 Adefovir Dipivoxil and polyene phosphatidylcholine;Adefovir Dipivoxil
40 Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral Agents Unknown status NCT02337127 Phase 4 Lamivudine
41 A Pilot Study to Assess the Efficacy and Safety of Folic Acid and/or Vitamin B Complex on Hepatitis C Infected Patients Treated With Pegylated Interferon and Ribavirin. Unknown status NCT02150291 Phase 4 Neurobion;placebo
42 Prednisolone Priming Study in Patients With Chronic Hepatitis B Unknown status NCT00778596 Phase 4 Prednisolone;Placebo priming
43 Active Drug Comparative Trial to Evaluate the Antiviral Activity and Safety in Chronic Hepatitis B Patients Unknown status NCT02588937 Phase 4 EntecaBell ODT. 0.5mg;Baraclude Tab. 0.5mg
44 Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection Unknown status NCT01594905 Phase 4 Entecavir + Tenofovir (MDR group)
45 Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis B Unknown status NCT00921180 Phase 4 Entecavir and peginterferon alfa-2a;Placebo and peginterferon
46 Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis B Unknown status NCT00917761 Phase 4 Entecavir and peginterferon (Pegasys) (52 weeks);Peginterferon (Pegasys) (96 weeks);Peginterferon (Pegasys) (48 weeks)
47 Improved Prevention of Perinatal Hepatitis B Transmission Unknown status NCT01133184 Phase 4
48 Two Different Treatments 24 vs 48 Weeks Chronic Hepatitis C Genotypes 2 and/or 3 in co-Infected HIV-HCV Unknown status NCT00611819 Phase 4 Peg interferon + Ribavirin;Peg interferon + Ribavirin
49 Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma Unknown status NCT00768157 Phase 4 antiviral treatment (lamivudine or entecavir)
50 PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR) Unknown status NCT01056172 Phase 4 Peginterferon alfa-2a and Ribavirin;Peginterferon alfa-2a and Ribavirin

Search NIH Clinical Center for Hepatitis a

Cochrane evidence based reviews: hepatitis a

Genetic Tests for Hepatitis a

Anatomical Context for Hepatitis a

MalaCards organs/tissues related to Hepatitis a:

39
Liver, Testes, Kidney, Bone, T Cells, Bone Marrow, B Cells

Publications for Hepatitis a

Articles related to Hepatitis a:

(show top 50) (show all 928)
id Title Authors Year
1
Immune Thrombocytopenic Purpura and Hemolytic Anemia Secondary to Hepatitis A. ( 28875001 )
2017
2
Prevalence of G6PD deficiency in Children with Hepatitis A. ( 28875002 )
2017
3
Sensitive Genotyping of Foodborne-Associated Human Noroviruses and Hepatitis A Virus Using an Array-Based Platform. ( 28930175 )
2017
4
Rapid and label-free electrochemical DNA biosensor for detecting hepatitis A virus. ( 28865923 )
2017
5
Current status and strategies for the control of viral hepatitis A in Korea. ( 28942621 )
2017
6
Potent neutralization of hepatitis A virus reveals a receptor mimic mechanism and the receptor recognition site. ( 28074040 )
2017
7
Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: a propensity score weighted landmark analysis. ( 28940673 )
2017
8
Persistence of Antibody to Hepatitis A Virus 20 Years After Receipt of Hepatitis A Vaccine in Alaska. ( 28092416 )
2017
9
TIM1 (HAVCR1) Is Not Essential for Cellular Entry of Either Quasi-enveloped or Naked Hepatitis A Virions. ( 28874468 )
2017
10
Seven-year follow-up of the immune response after one or two doses of inactivated hepatitis A vaccine given at 1A year of age in the Mendoza Province of Argentina. ( 28933624 )
2017
11
Pityriasis rosea in a patient with retrovirus infection and a history of syphilis and positive results of infection with hepatitis A virus, hepatitis B virus and hepatitis C virus. ( 28670260 )
2017
12
Physician Knowledge and Attitudes about Hepatitis A and Current Practices Regarding Hepatitis A Vaccination Delivery. ( 28089593 )
2017
13
Granulomatous hepatitis: a rare primary manifestation of disseminated histoplasmosis in a renal transplant recipient. ( 28617878 )
2017
14
Free fatty acids or high-concentration glucose enhances hepatitis A virus replication in association with a reduction in glucose-regulated protein 78 expression. ( 27986562 )
2017
15
Validation of HAV biomarker 2A for differential diagnostic of hepatitis A infected and vaccinated individuals using multiplex serology. ( 28919226 )
2017
16
Digital RT-PCR method for hepatitis A virus and norovirus quantification in soft berries. ( 27960104 )
2017
17
Notes from the Field: Increase in Reported Hepatitis A Infections Among Men Who Have Sex with Men - New York City, January-August 2017. ( 28934181 )
2017
18
Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention. ( 28887164 )
2017
19
Elimination of representative contaminant candidate list viruses, coxsackievirus, echovirus, hepatitis A virus, and norovirus, from water by coagulation processes. ( 28011355 )
2017
20
A Randomized Controlled Trial to Evaluate a Potential Hepatitis B Booster Vaccination Strategy Using Combined Hepatitis A and B Vaccine. ( 28060048 )
2017
21
Acute hepatitis A infection after hepatitis A immunity in a HIV-positive individual. ( 28860200 )
2017
22
Mapping a Type-specific Epitope by Monoclonal Antibody against VP3 Protein of Duck Hepatitis A Type 1 Virus. ( 28883462 )
2017
23
A large prolonged outbreak of hepatitis A associated with consumption of frozen berries, Italy, 2013-14. ( 28086079 )
2017
24
A Cluster of Hepatitis A Viral Infection in HSE South. ( 28952677 )
2017
25
Gutuo Jiejiu decoction improves survival of patients with severe alcoholic hepatitis: A retrospective cohort study. ( 28522913 )
2017
26
Development of a fast and efficient method for hepatitis A virus concentration from green onion. ( 28919035 )
2017
27
Prevalence of Hepatitis A Virus Antibody in Portuguese Travelers: A New Paradigm. ( 28926326 )
2017
28
Hepatitis A with Superadded Salmonella paratyphi A Infection Presenting with Exudative Pleural Effusion and Acalculous Cholecystitis. ( 28667735 )
2017
29
The serological markers of acute infection with hepatitis A, B, C, D, E and G viruses revisited. ( 28884240 )
2017
30
Histological improvement of liver fibrosis in well-treated patients with autoimmune hepatitis: A cohort study. ( 28834875 )
2017
31
Updated Dosing Instructions for Immune Globulin (Human) GamaSTAN S/D for Hepatitis A Virus Prophylaxis. ( 28910270 )
2017
32
Acute-on-chronic hepatitis. A case report of autoimmune hepatitis/primary sclerosing cholangitis/ulcerative colitis overlap syndrome in a 15-year-old patient. ( 28856287 )
2017
33
Fatal acute hepatic failure in a family infected with the hepatitis A virus subgenotype IB: A case report. ( 28858094 )
2017
34
The impact of race and ethnicity on mortality and healthcare utilization in alcoholic hepatitis: a cross-sectional study. ( 27724882 )
2016
35
Effect of SIRS and sepsis on mortality in alcoholic hepatitis: A systematic review and meta-analysis. ( 27782895 )
2016
36
Progressive liver failure post acute hepatitis A, over a three-month period, resulting in hepatorenal syndrome and death. ( 27247182 )
2016
37
Cynomolgus monkeys (Macaca fascicularis) experimentally infected with B19V and hepatitis A virus: no evidence of the co-infection as a cause of acute liver failure. ( 27074255 )
2016
38
International Air Travel to Ohio, USA, and the Impact on Malaria, Influenza, and Hepatitis A. ( 27123365 )
2016
39
Risk factors for hospitalisation and associated costs among patients with hepatitis A associated with imported pomegranate arils, United States, 2013. ( 27156991 )
2016
40
Evaluation of Immunostimulatory Effects of N-(2-Hydroxy) Propyl-3-Trimethylammonium Chitosan Chloride for Improving Live Attenuated Hepatitis A Virus Vaccine Efficacy. ( 27918250 )
2016
41
Therapeutic Efficacy and Safety of Paeoniae Radix Rubra Formulae in Relieving Hyperbilirubinemia Induced by Viral Hepatitis: A Meta-Analysis. ( 27047379 )
2016
42
Corticosteroids Versus Pentoxifylline for Severe Alcoholic Hepatitis: A Sequential Analysis of Randomized Controlled Trials. ( 27404293 )
2016
43
Single dose hepatitis A immunisation: 7A^5 year observational pilot study in Nicaraguan children to assess protective effectiveness and humoral immune memory response. ( 27601623 )
2016
44
Are municipal solid waste collectors at increased risk of Hepatitis A Virus infection? A Greek cross-sectional study. ( 28011965 )
2016
45
Co-infection of dengue fever and hepatitis A in a Russian traveler. ( 27516967 )
2016
46
Long-term durability of responses to 2 or 3 doses of hepatitis A vaccination in HIV-positive adults on antiretroviral therapy. ( 28011921 )
2016
47
Sporadic adult acute viral hepatitis in Northeast India is predominantly hepatitis A virus related. ( 27640427 )
2016
48
Pattern of Hepatitis A Virus Epidemiology in Nursing Students and Adherence to Preventive Measures at Two Training Wards of a University Hospital. ( 27195012 )
2016
49
Single-Dose Universal Hepatitis A Immunization in One Year Old Children in Argentina: High Prevalence of Protective Antibodies Up to 9 Years Following Vaccination. ( 27636725 )
2016
50
Performance and Utility of Transient Elastography and Non-Invasive Markers of Liver Fiibrosis in Patients with Autoimmune Hepatitis: A Single Centre Experience. ( 28070199 )
2016

Variations for Hepatitis a

Expression for Hepatitis a

Search GEO for disease gene expression data for Hepatitis a.

GO Terms for Hepatitis a

Cellular components related to Hepatitis a according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.81 AFP ALB F2 F3 IFNA2 SERPINA1
2 cell surface GO:0009986 9.77 F3 HAVCR2 HSPA5 TGFB1 TNF
3 blood microparticle GO:0072562 9.56 ALB F2 SERPINC1 TGFB1
4 platelet alpha granule lumen GO:0031093 9.5 ALB SERPINA1 TGFB1
5 endoplasmic reticulum lumen GO:0005788 9.43 AFP ALB F2 HSPA5 SERPINA1 SERPINC1
6 extracellular space GO:0005615 9.32 AFP ALB F2 F3 GPT IFNA2
7 extracellular exosome GO:0070062 10.01 ALB F2 F3 GPT HAVCR2 HSPA5

Biological processes related to Hepatitis a according to GeneCards Suite gene sharing:

(show all 17)
id Name GO ID Score Top Affiliating Genes
1 inflammatory response GO:0006954 9.78 HAVCR2 IFNA2 TGFB1 TNF
2 positive regulation of protein phosphorylation GO:0001934 9.74 F2 TGFB1 TNF
3 post-translational protein modification GO:0043687 9.71 AFP ALB SERPINA1 SERPINC1
4 negative regulation of gene expression GO:0010629 9.62 HAVCR2 IFNA2 TGFB1 TNF
5 platelet degranulation GO:0002576 9.61 ALB SERPINA1 TGFB1
6 positive regulation of protein localization to nucleus GO:1900182 9.56 F2 TGFB1
7 positive regulation of collagen biosynthetic process GO:0032967 9.55 F2 TGFB1
8 cellular protein metabolic process GO:0044267 9.55 AFP ALB F2 SERPINA1 SERPINC1
9 positive regulation of protein complex assembly GO:0031334 9.54 TGFB1 TNF
10 positive regulation of protein kinase B signaling GO:0051897 9.54 F3 TGFB1 TNF
11 regulation of blood coagulation GO:0030193 9.52 F2 SERPINC1
12 negative regulation of myoblast differentiation GO:0045662 9.51 TGFB1 TNF
13 positive regulation of NIK/NF-kappaB signaling GO:1901224 9.49 HAVCR2 TNF
14 positive regulation of chemokine production GO:0032722 9.46 HAVCR2 TNF
15 blood coagulation GO:0007596 9.35 F2 F3 IFNA2 SERPINA1 SERPINC1
16 positive regulation of mononuclear cell migration GO:0071677 9.26 TGFB1 TNF
17 hemostasis GO:0007599 8.92 F2 F3 SERPINA1 SERPINC1

Molecular functions related to Hepatitis a according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 protease binding GO:0002020 8.92 F3 SERPINA1 SERPINC1 TNF

Sources for Hepatitis a

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....